News Daily News FDA Proposes Ban on Menthol Cigarettes and Flavored Cigars Michael O'Riordan April 28, 2022
News Daily News USPSTF Finalizes Tougher Stance on Aspirin in Primary Prevention Shelley Wood April 26, 2022
News Daily News Don’t Rule Out CABG for Elderly Patients With Multiple Comorbidities Michael O'Riordan April 25, 2022
News Daily News Timely PCI May Outweigh Hospital Factors for ACS Patients With Cardiogenic Shock Caitlin E. Cox April 18, 2022
News Daily News Revascularization’s Benefits in HFrEF Linked to Gains in LV Function Caitlin E. Cox April 15, 2022
News Conference News ACC 2022 No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3 Michael O'Riordan April 13, 2022
News Daily News Myocarditis in Unvaxxed Patients Hospitalized With COVID-19: New Insights L.A. McKeown April 13, 2022
News Daily News Myopericarditis No More Common After COVID-19 Shots Than Other Vaccines Caitlin E. Cox April 12, 2022
News Conference News ACC 2022 Managing AF Patients Undergoing PCI—Some Lingering Questions Michael O'Riordan April 12, 2022
News Conference News ACC 2022 Modest Effects, Safety Concerns Plague Vupanorsen in TRANSLATE-TIMI 70 Michael O'Riordan April 07, 2022
News Conference News ACC 2022 In Vaccine Era, Deaths Drop Sharply in STEMI Patients With COVID-19 Caitlin E. Cox April 04, 2022
News Conference News ACC 2022 PACMAN-AMI: Positive Plaque Changes With Early Alirocumab Use in Acute MI Todd Neale April 03, 2022
News Conference News ACC 2022 APOLLO: Novel siRNA Injectable Cuts Lp(a) by Nearly 100% in Small Study Michael O'Riordan April 03, 2022
News Conference News ACC 2022 Better Angina Relief With Complete PCI in STEMI and MVD L.A. McKeown April 02, 2022
News Daily News Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention Michael O'Riordan March 30, 2022
News Conference News ACC 2022 What’s Going to Be Hot at ACC 2022, In Person or Virtual Shelley Wood March 28, 2022
News Conference News ACC 2022 Nitroglycerin Given Early or Late Fails to Prevent Radial Artery Occlusion: PATENS Michael O'Riordan March 25, 2022